Skip to main content

Peer Review reports

From: Antibacterial activities and action mode of anti-hyperlipidemic lomitapide against Staphylococcus aureus

Original Submission
15 Feb 2022 Submitted Original manuscript
23 Feb 2022 Reviewed Reviewer Report - Payam Behzadi
10 Mar 2022 Reviewed Reviewer Report
25 Mar 2022 Author responded Author comments - Zewen Wen
Resubmission - Version 2
25 Mar 2022 Submitted Manuscript version 2
29 Mar 2022 Author responded Author comments - Zewen Wen
Resubmission - Version 3
29 Mar 2022 Submitted Manuscript version 3
4 Apr 2022 Author responded Author comments - Zewen Wen
Resubmission - Version 4
4 Apr 2022 Submitted Manuscript version 4
7 Apr 2022 Author responded Author comments - Zewen Wen
Resubmission - Version 5
7 Apr 2022 Submitted Manuscript version 5
8 Apr 2022 Author responded Author comments - Zewen Wen
Resubmission - Version 6
8 Apr 2022 Submitted Manuscript version 6
11 Apr 2022 Reviewed Reviewer Report - Payam Behzadi
14 Apr 2022 Reviewed Reviewer Report
Resubmission - Version 7
Submitted Manuscript version 7
Publishing
18 Apr 2022 Editorially accepted
26 Apr 2022 Article published 10.1186/s12866-022-02535-9

You can find further information about peer review here.

Back to article page